4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000004
CFO AND TREASURER sold 10,000 shares at an average $535.90 ($5,359,005)
- CFO AND TREASURER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $135.42 | $1,354,200 | 28,876 | D |
| 2026-03-26 | Sale : show line 2 in the form 10b5-1 | −991 | $532.02 | $527,236 | 27,885 | D |
| 2026-03-26 | Sale : show line 3 in the form 10b5-1 | −510 | $532.93 | $271,794 | 27,375 | D |
| 2026-03-26 | Sale : show line 4 in the form 10b5-1 | −609 | $533.91 | $325,153 | 26,766 | D |
| 2026-03-26 | Sale : show line 5 in the form 10b5-1 | −1,847 | $534.98 | $988,101 | 24,919 | D |
| 2026-03-26 | Sale : show line 6 in the form 10b5-1 | −2,003 | $535.94 | $1,073,491 | 22,916 | D |
| 2026-03-26 | Sale : show line 7 in the form 10b5-1 | −1,577 | $536.90 | $846,689 | 21,339 | D |
| 2026-03-26 | Sale : show line 8 in the form 10b5-1 | −1,149 | $537.90 | $618,046 | 20,190 | D |
| 2026-03-26 | Sale : show line 9 in the form 10b5-1 | −994 | $538.91 | $535,680 | 19,196 | D |
| 2026-03-26 | Sale : show line 10 in the form 10b5-1 | −320 | $540.04 | $172,814 | 18,876 | D |
| Open-market sales · 10,000 sh · avg $535.90 · $5,359,005 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-26 | Exercise or conversion : show line 11 in the form 10b5-1 Stock Option | −10,000 | 142,500 | D |
Loading xslF345X06/primarydocument.xml…